Clara O Sailer Selected Research

Psychogenic Polydipsia

1/2022	Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
10/2021	A randomized controlled trial of the GLP-1 receptor agonist dulaglutide in primary polydipsia.
11/2020	Effects of glucagon-like peptide-1 receptor agonists on fluid intake in healthy volunteers.
1/2019	Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study.
1/2018	Reply to comment on: Sailer CO, et al. Primary polydipsia in the medical and psychiatric patient: characteristics, complications and therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clara O Sailer Research Topics

Disease

5	Psychogenic Polydipsia 01/2022 - 01/2018
5	Hyponatremia 11/2021 - 01/2019
2	Diabetes Insipidus 10/2020 - 01/2019
1	Pneumonia (Pneumonitis) 01/2022
1	Autonomic Dysreflexia 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Hypopituitarism (Sheehan's Syndrome) 08/2021
1	Hypernatremia 03/2021
1	Hypotension (Low Blood Pressure) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Polyuria 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019

Drug/Important Bio-Agent (IBA)

2	dulaglutideIBA 01/2022 - 10/2021
2	Sodium Chloride FDA LinkGeneric 01/2022 - 10/2021
2	empagliflozinIBA 11/2021 - 01/2020
2	ElectrolytesIBA 01/2020 - 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2021
1	Oxytocin (Pitocin)FDA LinkGeneric 08/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2020
1	Arginine Vasopressin (Argipressin)IBA 10/2020
1	Arginine (L-Arginine)FDA Link 01/2019
1	SodiumIBA 01/2019
1	DiureticsIBA 01/2019
1	Growth Hormone (Somatotropin)IBA 01/2019

Therapy/Procedure

1	Length of Stay 01/2022
1	Subcutaneous Injections 01/2022
1	Artificial Respiration (Mechanical Ventilation) 03/2021
1	Therapeutics 01/2018